BiffiR., CorradoF., De BraudF., De LuciaF., ScarpaD., TestoriA., OrsiF., BellomiM., MauriS., AaproM., AndreoniB.: Long term, totally implantable central venous access ports connected to Groshong catheter for chemotherapy of solid tumours: experience on 178 cases using a single type of device.Eur J Cancer, 33: 1190–1194, 1997.
2.
BiffiR., De BraudF., OrsiF., PozziS., MauriS., GoldhirschA., NolèF., AndreoniB.: Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.Ann Oncol, 9: 767–773, 1998.
3.
BowE.J., KilpatrickM.G., ClinchJ.J.: Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.J Clin Oncol, 17: 1267–1273, 1999.
4.
BroadwaterJ.R., HendersonM.J., SmithG.J.: Outpatient percutaneous central venous access in cancer patients.Am J Surg, 160: 676–680, 1990.
5.
BrothersT.E., Von MollL.K., NiederhuberJ.E., RobertsJ.A., Walker-AndrewsS., EnsmingerW.D.: Experience with subcutaneous infusion ports in three hundred patients.Surg Gynecol Obstet, 166: 295–301, 1988.
6.
KooningsP.P., GivenF.T.: Long term experience with a totally implanted catheter system in gynecologic oncologic patients.J Am Coll Surg, 178: 164–166, 1994.
7.
McCreadyD., BroadwaterR., RossM., PollockR., OtaD., BalchC.: A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients.J Surg Res, 51: 377–381, 1991.
8.
MuellerB.U., SkeltonJ., CallenderD.P.E.: A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.J Clin Oncol, 10: 1943–1948, 1992.
9.
SchumanE., BradyA., GrossG., HayesJ.: Vascular access options for outpatient cancer therapy.Am J Surg, 153: 487–489, 1987.
